Logo image of LYEL

LYELL IMMUNOPHARMA INC (LYEL) Stock Analyst Ratings

NASDAQ:LYEL - Nasdaq - US55083R1041 - Common Stock - Currency: USD

7.94  +7.5 (+1704.55%)

Buy % Consensus

47

ChartMill assigns a Buy % Consensus number of 47% to LYEL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.82. This target is -89.72% below the current price.
LYEL was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about LYEL.
In the previous month the buy percentage consensus was at a similar level.
LYEL was analyzed by 9 analysts. More opinions would make the average more meaningful.
LYEL Historical Analyst RatingsLYEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 7.940.610.820.821.05 - -92.37% -89.72% -89.72% -86.78%
LYEL Current Analyst RatingLYEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-04-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-03-13 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-11-12 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-10-30 B of A Securities Downgrade Buy -> Underperform
2024-10-28 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-19 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-06-27 B of A Securities Maintains Buy -> Buy
2024-06-27 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-05-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-29 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-09 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-28 JP Morgan Downgrade Overweight -> Neutral
2023-05-05 HC Wainwright & Co. Reiterate Buy
2023-03-02 HC Wainwright & Co. Maintains Buy
2023-01-24 Morgan Stanley Maintains Equal-Weight
2022-11-14 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-11-11 Goldman Sachs Downgrade Buy -> Neutral
2022-10-17 HC Wainwright & Co. Initiate Buy
2022-05-24 Goldman Sachs Maintains Buy
2022-01-06 Morgan Stanley Maintains Overweight
2021-07-12 JP Morgan Initiate Overweight
2021-07-12 Goldman Sachs Initiate Buy
2021-07-12 B of A Securities Initiate Buy
2021-07-12 Morgan Stanley Initiate Overweight